Frank R. Crantz

1.4k total citations
11 papers, 1.1k citations indexed

About

Frank R. Crantz is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Frank R. Crantz has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Physiology. Recurrent topics in Frank R. Crantz's work include Thyroid Disorders and Treatments (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Vitamin K Research Studies (2 papers). Frank R. Crantz is often cited by papers focused on Thyroid Disorders and Treatments (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Vitamin K Research Studies (2 papers). Frank R. Crantz collaborates with scholars based in United States and Germany. Frank R. Crantz's co-authors include J. E. Silva, P. Reed Larsen, P R Larsen, Jack L. Leonard, P. Reed Larsen, Mackenzie Walser, A.W. Coulter, Gordon H. Williams, Stephen L. Swartz and Robert G. Dluhy and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Endocrinology.

In The Last Decade

Frank R. Crantz

10 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank R. Crantz United States 10 588 291 245 170 137 11 1.1k
Richard H. Underwood United States 17 594 1.0× 287 1.0× 133 0.5× 232 1.4× 137 1.0× 42 1.1k
W Nowaczynski Canada 23 905 1.5× 334 1.1× 163 0.7× 376 2.2× 127 0.9× 98 1.8k
N. Kalant Canada 22 352 0.6× 516 1.8× 440 1.8× 79 0.5× 103 0.8× 105 1.6k
M A Devynck France 17 226 0.4× 477 1.6× 347 1.4× 259 1.5× 130 0.9× 67 1.1k
Ignasi Ramı́rez Spain 21 266 0.5× 348 1.2× 311 1.3× 235 1.4× 127 0.9× 52 1.1k
Marie-Gabrielle Pernollet France 19 250 0.4× 694 2.4× 319 1.3× 285 1.7× 175 1.3× 56 1.2k
Gladys Perisutti United States 22 585 1.0× 315 1.1× 216 0.9× 211 1.2× 57 0.4× 42 1.2k
P. Vecsei Germany 17 749 1.3× 455 1.6× 147 0.6× 423 2.5× 52 0.4× 86 1.5k
Philip G. Baer United States 17 229 0.4× 367 1.3× 166 0.7× 183 1.1× 104 0.8× 47 1.2k
Keiichi Yamatani Japan 19 350 0.6× 331 1.1× 181 0.7× 54 0.3× 124 0.9× 60 916

Countries citing papers authored by Frank R. Crantz

Since Specialization
Citations

This map shows the geographic impact of Frank R. Crantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank R. Crantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank R. Crantz more than expected).

Fields of papers citing papers by Frank R. Crantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank R. Crantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank R. Crantz. The network helps show where Frank R. Crantz may publish in the future.

Co-authorship network of co-authors of Frank R. Crantz

This figure shows the co-authorship network connecting the top 25 collaborators of Frank R. Crantz. A scholar is included among the top collaborators of Frank R. Crantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank R. Crantz. Frank R. Crantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gordon, Murray B., et al.. (1984). Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.. Journal of Clinical Investigation. 73(4). 898–907. 99 indexed citations
2.
Koletsky, Richard J., Robert G. Dluhy, Frank R. Crantz, & Gordon H. Williams. (1982). Cortisol Suppression Test in Patients with Elevated Adrenocorticotropic Hormone Levels. Annals of Internal Medicine. 96(3). 277–280.
3.
Leonard, Jack L., et al.. (1982). Evidence for Two Tissue-specific Pathways for In Vivo Thyroxine 5′-Deiodination in the Rat. Journal of Clinical Investigation. 69(5). 1176–1184. 124 indexed citations
4.
Crantz, Frank R., J. E. Silva, & P. Reed Larsen. (1982). An Analysis of the Sources and Quantity of 3,5,3′-Triiodothyronine Specifically Bound to Nuclear Receptors in Rat Cerebral Cortex and Cerebellum*. Endocrinology. 110(2). 367–375. 290 indexed citations
5.
Kaplan, Michael M., P. Reed Larsen, Frank R. Crantz, et al.. (1982). Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. The American Journal of Medicine. 72(1). 9–16. 121 indexed citations
6.
Moore, Thomas J., Frank R. Crantz, N. K. Hollenberg, et al.. (1981). Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.. Hypertension. 3(2). 168–173. 171 indexed citations
7.
Swartz, Stephen L., Gordon H. Williams, Norman K. Hollenberg, et al.. (1980). Increase in Prostaglandins during Converting Enzyme Inhibition. Clinical Science. 59(s6). 133s–135s. 28 indexed citations
8.
Swartz, Stephen L., Gordon H. Williams, Norman K. Hollenberg, et al.. (1980). Endocrine profile in the long-term phase of converting-enzyme inhibition. Clinical Pharmacology & Therapeutics. 28(4). 499–508. 30 indexed citations
9.
Crantz, Frank R. & P R Larsen. (1980). Rapid Thyroxine to 3,5,3′-Triiodothyronine Conversion and Nuclear 3,5,3′-Triiodothyronine Binding in Rat Cerebral Cortex and Cerebellum. Journal of Clinical Investigation. 65(4). 935–938. 118 indexed citations
10.
Crantz, Frank R., Stephen L. Swartz, Norman K. Hollenberg, et al.. (1980). Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension.. Hypertension. 2(5). 604–609. 24 indexed citations
11.
Walser, Mackenzie, et al.. (1973). The Effect of Keto-analogues of Essential Amino Acids in Severe Chronic Uremia. Journal of Clinical Investigation. 52(3). 678–690. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026